John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with Ben Bobo. In the interview he discusses his own personal journey into genomics and how SimplSeq is poised to disrupt the sequencing industry. View the interview here.
Tags: #simplseq, genomics, Precision Medicine
This post was written by mgjay